Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6

Affiliations

¹ Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
² Medical Examination Center, The Second People's Hospital of Liaocheng, Liaocheng, China.
³ Department of Urology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: arfuzinss@sina.com.
⁴ Department of Obstetrics and Gynecology, West China Second University Hospital, Chengdu, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Chengdu, China.

Comment

Yi Sun et al. Eur Urol. 2021 Jan.

. 2021 Jan;79(1):e14-e15.

doi: 10.1016/j.eururo.2020.10.002. Epub 2020 Oct 26.

¹ Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
² Medical Examination Center, The Second People's Hospital of Liaocheng, Liaocheng, China.
³ Department of Urology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: arfuzinss@sina.com.
⁴ Department of Obstetrics and Gynecology, West China Second University Hospital, Chengdu, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Chengdu, China.

No abstract available

Comment in

Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence.
Vickers A, Carlsson SV, Cooperberg M. Vickers A, et al. Eur Urol. 2020 Sep;78(3):304-306. doi: 10.1016/j.eururo.2020.04.016. Epub 2020 May 7. Eur Urol. 2020. PMID: 32389443 Free PMC article.